Dayton Misfeldt, Director at SUNESIS PHARMACEUTICALS INC (SNSS), sold 635,702 shares at $3.46 ($2.2M) on 2015-07-24, disclosed to the SEC on 2015-12-21.
Open-market sale of $2.2M SNSS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.46 | 7,925 | $27K | 1.2% |
| 2 | $3.46 | 207,938 | $719K | 32.7% |
| 3 | $3.46 | 415,877 | $1.4M | 65.4% |
| 4 | $3.64 | 3,962 | $14K | 0.7% |
| Total | $3.46 avg | 635,702 | $2.2M | 100% |
| Filing → |
| SNSS | SELL | 2014-08-29 | $2.4M | — | Filing → |
| SNSS | SELL | 2014-08-12 | $4.9M | — | Filing → |
| SNSS | BUY | 2010-07-01 | $6.7M | — | Filing → |